# Overview
Dabigatran is an oral anticoagulant that belongs to a class of medications known as direct thrombin inhibitors. It is used primarily to reduce the risk of stroke in patients with non-valvular atrial fibrillation, and for the treatment and prevention of deep vein thrombosis and pulmonary embolism. By inhibiting thrombin, dabigatran prevents the formation of blood clots.

## Main Effects and Uses
- **Reduces risk of stroke** in patients with non-valvular atrial fibrillation.
- **Prevention and treatment of** deep vein thrombosis (DVT) and pulmonary embolism (PE).
- **Prevention of blood clots** in patients undergoing hip or knee replacement surgery.

# Side Effects
## Serious Side Effects
- **Bleeding complications** (e.g., gastrointestinal bleeding, intracranial hemorrhage)
- **Severe allergic reactions** (e.g., anaphylaxis)
- **Liver dysfunction** 
- **Thrombocytopenia** (low platelet count)

## Other Side Effects
- Nausea
- Diarrhea
- Indigestion or dyspepsia
- Abdominal pain
- Headache
- Skin rash
- Elevated liver enzymes

# Interactions
Dabigatran may interact with several other medications, which can affect its efficacy or increase the risk of bleeding. Notably, it is important to consider the following interactions:
- **Other anticoagulants** (e.g., warfarin, rivaroxaban) which increase the risk of bleeding.
- **P-glycoprotein inhibitors** (e.g., verapamil, amiodarone) may increase dabigatran levels, raising the risk of bleeding.
- **P-glycoprotein inducers** (e.g., rifampin, St. John's wort) may decrease dabigatran levels, reducing its effectiveness.

It's essential for patients to inform their healthcare provider about all medications they are taking to avoid potential interactions.